These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20863459)

  • 1. [Studies on relationship between myc family oncogene overexpression and prognosis of lung cancer.].
    Bai L; Sun Y; Li S
    Zhongguo Fei Ai Za Zhi; 1998 Jul; 1(1):29-31. PubMed ID: 20863459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of p53 alteration and myc family gene overexpression with the clinical characteristics of lung cancer.
    Bai L; Sun Y; Li S
    Chin Med J (Engl); 1997 Apr; 110(4):250-4. PubMed ID: 9594222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on genes associated with biologic behavior in human lung cancer].
    Bai L; Sun Y; Li S
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):23-5. PubMed ID: 11263295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes.
    Yokota J; Wada M; Yoshida T; Noguchi M; Terasaki T; Shimosato Y; Sugimura T; Terada M
    Oncogene; 1988 Jun; 2(6):607-11. PubMed ID: 2838790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship of mdr1 gene expression and multidrug resistance of primary lung cancer].
    Bai L; Sun Y; Li S
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Feb; 20(1):30-2. PubMed ID: 10072799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression of c-myc protein in uterine cervical cancer: a possible prognostic indicator].
    Wu HJ
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jul; 48(7):515-21. PubMed ID: 8754393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expression of MRP gene relates to the pathological features of lung cancer].
    Wang Y; Wang A; Zhang W
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Sep; 22(9):545-7. PubMed ID: 11776768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relationship between Epstein-Barr-virus infection and expression of p53, Bcl-2 and C-myc gene in lung cancer].
    Xia H; Wu J; Chen C; Mao Y; Zhu J; Chang Q; Mi K; Zhao J; Zhang M
    Zhongguo Fei Ai Za Zhi; 2000 Aug; 3(4):265-8. PubMed ID: 20955673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients.
    Scorilas A; Yotis J; Gouriotis D; Keramopoulos A; Ampela K; Trangas T; Talieri M
    Anticancer Res; 1993; 13(5C):1895-900. PubMed ID: 7903524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
    Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
    J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer].
    Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
    Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
    Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of oncogene and anti-oncogene in mouse lung cancer induced by coal-burning smoke].
    Lin C; Dai X; Sun X
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):432-4. PubMed ID: 8697995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the c-myc proto-oncogene in colorectal carcinoma is associated with a reduced mortality that is abrogated by point mutation of the p53 tumor suppressor gene.
    Smith DR; Goh HS
    Clin Cancer Res; 1996 Jun; 2(6):1049-53. PubMed ID: 9816266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal expression of pan-ras, c-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis.
    Ngan HY; Cheung AN; Liu SS; Cheng DK; Ng TY; Wong LC
    Oncol Rep; 2001; 8(3):557-61. PubMed ID: 11295080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
    Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of prognostic factors in patients with stage I non-small cell lung cancer].
    Jiang ZQ; Jiang GL; Shi DR; Zhang RX; Fu XL; Qian H
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):364-8. PubMed ID: 15312349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.